Location History:
- St. Charles, MO (US) (2010)
- St. Louis, MO (US) (2021)
- Wentzville, MO (US) (2011 - 2022)
Company Filing History:
7 out of 219 
2 out of 4,455 
2 out of 1,586 
Years Active: 2010-2025
Title: Marvin Jay Meyers: Innovator in Biomedical Research
Introduction
Marvin Jay Meyers is a notable inventor based in Wentzville, MO (US), recognized for his contributions to biomedical research. With a total of 9 patents, he has made significant advancements in the field of medical treatments and therapies.
Latest Patents
One of his latest patents is focused on a fatty acid modified human epidermal growth factor. This innovation provides new epidermal growth factor (EGF)-based reagents that have been modified through fatty acid conjugation. The patent also describes methods for using these agents to treat Short Bowel Syndrome (SBS). Another significant patent involves inhibitors of nucleotidyl transferases, which are relevant in the treatment of herpes and hepatitis viral infections. This disclosure relates to the identification of inhibitors that can effectively hinder the replication of hepatitis and herpesviruses, including specific compounds and their applications in treatment.
Career Highlights
Throughout his career, Marvin has worked with esteemed organizations such as Saint Louis University and Pfizer Corporation. His work in these institutions has allowed him to collaborate on various innovative projects that have contributed to advancements in medical science.
Collaborations
Marvin has collaborated with notable colleagues, including John Edwin Tavis and Stacy D Arnett. Their combined expertise has fostered a productive environment for research and development in their respective fields.
Conclusion
Marvin Jay Meyers stands out as a significant figure in biomedical innovation, with a focus on developing treatments for critical health issues. His patents and collaborations reflect his commitment to advancing medical science and improving patient care.